Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
3-nitrotyrosine (3-NT)
7%
Adjuvant Therapy
7%
Aldose Reductase Inhibitor
100%
Anthracycline Chemotherapy
7%
Aorta
7%
AR Inhibitors
7%
Blood Cancer
7%
Breast Cancer
7%
Cancer Cell Death
7%
Cardiac Cells
7%
Cardiomyopathy
7%
Cardiotoxicity
23%
Cardiovascular Complications
7%
Caspase-3
7%
Cell Dysfunction
7%
Cell Hypertrophy
7%
Cell Toxicity
7%
Cellular Expression
7%
Chemotherapy Agents
7%
Chemotherapy Efficacy
7%
Colon Cancer
7%
Colon Cancer Cells
7%
Cytotoxicity
7%
Doxorubicin
100%
Drug Resistance
7%
Endothelial Cell Death
100%
Endothelial Cell Dysfunction
100%
Endothelial Dysfunction
7%
Endothelial Nitric Oxide Synthase (eNOS)
15%
Fidarestat
100%
High Dose
7%
Human Umbilical Vein Endothelial Cells (HUVECs)
38%
Incubation
7%
Induced Endothelial Cells
100%
Induced Expression
7%
Induced Oxidative Stress
7%
Inducible Nitric Oxide Synthase
7%
Inflammatory Chemokines
15%
Inflammatory Cytokines
15%
Intercellular Adhesion molecule-1 (ICAM-1)
7%
Lung Cancer
7%
Monocyte Adhesion
7%
NF-B
7%
Nitric Oxide Levels
7%
Oxygen Activation
7%
Reactive Oxygen Species
7%
Vascular Cell Adhesion molecule-1 (VCAM-1)
7%
Pharmacology, Toxicology and Pharmaceutical Science
3 Nitrotyrosine
7%
Aldose Reductase Inhibitor
100%
Anthracycline
7%
Breast Cancer
7%
Cardiotoxicity
15%
Cardiovascular Disease
7%
Caspase 3
7%
Chemokine
15%
Chemotherapy Agent
7%
Chemotherapy Regimens
7%
Colon Carcinoma
15%
Cytokine
15%
Cytotoxicity
15%
Doxorubicin
100%
Drug Resistance
7%
Endothelial Dysfunction
7%
Fidarestat
100%
Intercellular Adhesion Molecule 1
7%
Lung Cancer
7%
Myocardial Disease
7%
Nitric Oxide
7%
Reactive Oxygen Metabolite
7%
Side Effect
7%
Vascular Cell Adhesion Molecule 1
7%